EP Patent

EP3946427C0 — DRUG DELIVERY SYSTEMS AND METHODS

Assigned to Amphastar Pharmaceuticals Inc · Expires 2024-05-08 · 2y expired

What this patent protects

Patent listed against Glucagen.

Drugs covered by this patent

Glucagen (GLUCAGON) · Xeris

Patent Metadata

Patent number: EP3946427C0
Jurisdiction: EP
Classification: —
Expires: 2024-05-08
Drug substance claim: No
Drug product claim: No
Assignee: Amphastar Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.